hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06329193 id: CBU-FTR-ES-O4 briefTitle: Effects of Mid-Season Camp Period Loading on Sports Injury Anxiety and Physical Performance overallStatus: NOT_YET_RECRUITING date: 2024-04-15 date: 2024-05-07 date: 2024-05-15 date: 2024-03-25 date: 2024-03-25 name: Celal Bayar University class: OTHER briefSummary: The aim of this study is to investigate the effects of 3-week mid-season camp period loading on sports injury anxiety level and physical performances of professional male soccer players. conditions: Anxiety conditions: Exercise conditions: Athletic Performance studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: PREVENTION masking: NONE count: 34 type: ESTIMATED name: Mid-Season Camp Period Loading measure: Sports Injury Anxiety measure: Muscle strength measure: Flexibility measure: Dynamic balance measure: Single-leg jump measure: Agility measure: Sprint sex: MALE minimumAge: 19 Years maximumAge: 22 Years stdAges: ADULT hasResults: False
nctId: NCT06329180 id: 26.02.2024 briefTitle: Exercise in Mental Illness Questionnaire: French Validation overallStatus: ENROLLING_BY_INVITATION date: 2024-03-19 date: 2024-06-01 date: 2024-06-01 date: 2024-03-25 date: 2024-03-25 name: KU Leuven class: OTHER briefSummary: The validation of the French version of the Exercise in Mental Illness Questionnaire - Health Practitioner Version (EMIQ-HP) is a prospective observational case-only study involving: (a) translation to French, (b) an expert consensus meeting with French speaking experts from Canada to reach a first version, (c) back translation to English, (d) evaluation of the back-translation by the original authors of the EMIQ-HP, (e) an expert consensus meeting with French speaking experts from Canada to reach a final version based on comments of the original authors, and (f) test-retest reliability study. Test-retest reliability will be analysed through two points of measurement with an interval of 7 days. conditions: Exercise studyType: OBSERVATIONAL observationalModel: CASE_CONTROL timePerspective: CROSS_SECTIONAL count: 42 type: ESTIMATED measure: Intra-class-correlation coefficients (ICC 3,1 sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Centre Hospitalier Psychiatrique Chêne aux Haies city: Mons country: Belgium lat: 50.45413 lon: 3.95229 hasResults: False
nctId: NCT06329167 id: 2024-HS-012 briefTitle: Daphnetin Capsules for Lower Limb Lymphoedema Following Gynaecological Surgery overallStatus: RECRUITING date: 2024-03-25 date: 2025-07-01 date: 2025-07-31 date: 2024-03-25 date: 2024-03-25 name: The First Hospital of Jilin University class: OTHER briefSummary: This clinical trial is designed to learn more about treating patients with lower limb lymphoedema following gynaecological surgery. The main question to be answered is To evaluate the efficacy of Daphnetin capsule in the treatment of patients with lower limb lymphedema following gynaecological malignancy surgery. Participants will take Daphnetin capsule 150mg tid (3 capsules/time, 3 times daily) orally at the same time as gradient compression stocking treatment. Researchers will compare 150mg Forte tablets (2 capsules/time, 2 times daily) and gradient compression stockings to see if Daphnetin capsule can be used to treat patients with lower extremity lymphedema following gynaecological malignancy surgery. conditions: Lower Extremity Lymphedema studyType: INTERVENTIONAL phases: PHASE4 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 100 type: ESTIMATED name: Daphnetin name: Aescuven measure: The difference in the circumference of the lower limbs measure: Gynaecological Cancer Lymphedema Questionnaire measure: Fibrinogen content sex: FEMALE minimumAge: 18 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT facility: the 1st hospital of Jilin University status: RECRUITING city: Chang Chun state: Jilin country: China name: Xiaosen Li Li role: CONTACT phone: +8618343116682 email: xiaosensen@jlu.edu.cn lat: 42.74694 lon: 126.24667 hasResults: False
nctId: NCT06329154 id: PJ-KS-KY-2024-03(X) briefTitle: Clinical Study On Extracorporeal Shock Wave Therapy For Rotator Cuff Injuries overallStatus: RECRUITING date: 2024-02-27 date: 2025-01-27 date: 2025-02-27 date: 2024-03-25 date: 2024-03-25 name: Yong Liu, MD class: OTHER briefSummary: This clinical trial aims to learn about the effect of extracorporeal shock wave therapy on rotator cuff injuries. The main question it aims to answer is the efficacy of extracorporeal shock wave therapy on the improvement of pain, shoulder function, and quality of life in patients with rotator cuff injuries. The experimental group of patients received extracorporeal shock wave therapy combined with conventional rehabilitation therapy. The control group only received conventional rehabilitation therapy. Compare the two groups to explore the therapeutic effect of extracorporeal shock wave therapy on rotator cuff injuries. conditions: Rotator Cuff Injuries studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE maskingDescription: assessor was blinded. The assessor, who not participated in the study, was experienced, and well qualified in the use. whoMasked: OUTCOMES_ASSESSOR count: 58 type: ESTIMATED name: Extracorporeal shock wave therapy name: conventional rehabilitation therapy measure: Change from Baseline Visual Analogue Scale at 4 weeks measure: Change from Baseline Range of Motion at 4 weeks measure: Change from Baseline Constant-Murley Score at 4 weeks measure: Change from Baseline Isokinetic muscle strength testing at 4 weeks measure: Change from Baseline Magnetic resonance imaging at 4 weeks measure: Change from Baseline Musculoskeletal ultrasound at 4 weeks measure: Change from Baseline American Shoulder and Elbow Surgeons Score at 4 weeks measure: Change from Baseline Shoulder Pain and Disability Index at 4 weeks measure: Change from Baseline Disability of the Arm, Shoulder and Hand Score at 4 weeks measure: Change from Baseline University of California at Los Angeles Shoulder Scale at 4 weeks measure: Change from Baseline Pittsburgh sleep quality index at 4 weeks sex: ALL minimumAge: 20 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT facility: The First Affiliated Hospital of Dalian Medical University status: RECRUITING city: Dalian state: Liaoning zip: 116011 country: China name: yong liu role: CONTACT phone: 18098876656 email: fuwa52008@126.com lat: 38.91222 lon: 121.60222 hasResults: False
nctId: NCT06329141 id: HSG4112-P2-03 briefTitle: A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients overallStatus: NOT_YET_RECRUITING date: 2024-07-01 date: 2025-12-31 date: 2026-06-30 date: 2024-03-25 date: 2024-03-25 name: Glaceum class: INDUSTRY briefSummary: 1. Study Objective
3. Study Design and Protocol This study is a randomized, double-blind, placebo-controlled, parallel-group trial. Subjects deemed eligible to participate in this study based on the inclusion/exclusion criteria will be assigned a subject number and randomized to one of the 3 treatment groups - 1 group receiving a placebo - in a 1:1:1 ratio. Subjects will be randomized to double-blind treatments and will receive a once-daily oral dose of the investigational product for 24 weeks according to the study protocol. Several parameters (i.e., MDS-UPDRS, CGI-C, K-NMSS, modified Hoehn-Yahr stage and SNBR) will be evaluated to assess the efficacy of vutiglabridin. Assessments including measurement of vital signs, 12-lead ECG, clinical laboratory test, pregnancy test, physical examination, and adverse event monitoring will be performed to evaluate the safety and tolerability of vutiglabridin. Blood samples will be collected for pharmacokinetic assessment. conditions: Parkinson Disease studyType: INTERVENTIONAL phases: PHASE2 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 90 type: ESTIMATED name: Vutiglabridin name: Placebo measure: Change From Baseline in MDS-UPDRS Part III Subscore measure: Change From Baseline in MDS-UPDRS Part III Subscore measure: Change From Baseline in MDS-UPDRS Part II + Part III measure: Change From Baseline in CGI-C score measure: Change From Baseline in K-NMSS score measure: Change From Baseline in Modified Hoehn-Yahr stage measure: Change From Baseline in PET SNBR (Specific to Non-specific Binding Ratio) in the putamen, acudate and nucleus measure: Drop-out rate due to taking anti-parkinson drug sex: ALL minimumAge: 40 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06329128 id: 2022/04 briefTitle: Evaluation of the Effectiveness of Manual Therapy in Patients With Knee Osteoarthritis overallStatus: NOT_YET_RECRUITING date: 2024-03-25 date: 2024-06-30 date: 2024-09-30 date: 2024-03-25 date: 2024-03-25 name: Hasan Kalyoncu University class: OTHER briefSummary: The aim of this study is to investigate the effects of three different applications (Manual therapy, electrotherapy and home program) on long-term pain, joint range of motion and, secondarily, the functional level of the knee. conditions: Osteoarthritis, Knee studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Participants were divided in two groups. One groups will get electrotherapy, exercise(home programme) and manuel therapy intervention. One group will be the control group. Control group will get electrotherapy and exercise (home programme). primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 40 type: ESTIMATED name: Experimental: Study Group name: Active Comparator: Control Group measure: The pain measure: Functional status measure: The quality of Life measure: Lower extremity functional strength and balance test measure: Functional mobility sex: ALL minimumAge: 40 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Hasan Kalyoncu University city: Gaziantep state: Şahinbey zip: 27100 country: Turkey lat: 37.05944 lon: 37.3825 hasResults: False
nctId: NCT06329115 id: 2024/23 briefTitle: Investigation of the Effectiveness of Regular Physical Activity in University Students overallStatus: NOT_YET_RECRUITING date: 2024-03-25 date: 2024-06-30 date: 2024-06-30 date: 2024-03-25 date: 2024-03-25 name: Hasan Kalyoncu University class: OTHER briefSummary: In our study, university students who coded the course from various faculties and departments within the scope of a university-wide free elective course, after regular physical activity; It was aimed to examine the effects on lifelong learning, physical activity, fatigue, sleepiness, depression, anxiety and stress levels, quality of life and walking distances and physiological expenditure indices. conditions: Regular Physical Activity conditions: Exercise studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP interventionModelDescription: Participants will be included in an 8-week regular exercise program. Evaluations will be made before and after exercise. primaryPurpose: TREATMENT masking: NONE count: 100 type: ESTIMATED name: Exercise training measure: Lifelong learning measure: Physical activity measure: Fatique measure: Daytime sleepiness measure: Depression, anxiety and stress measure: Quality of life measurement measure: Physiological expenditure indices sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Hasan Kalyoncu University city: Gaziantep state: Şahinbey zip: 27100 country: Turkey lat: 37.05944 lon: 37.3825 hasResults: False
nctId: NCT06329089 id: HCB/2023/0840 briefTitle: Reoperative Sentinel Lymph Node Biopsy in Patients With Recurrent Ipsilateral Breast Cancer acronym: RENATA overallStatus: RECRUITING date: 2024-01-01 date: 2024-12-31 date: 2025-12-31 date: 2024-03-25 date: 2024-03-25 name: Hospital Clinic of Barcelona class: OTHER briefSummary: The goal of this observational study is to assess the effectiveness of sentinel lymph node biopsy as a treatment approach for patients with recurrent breast cancer on the same side as previous surgeries. The main questions it aims to answer are:
Participants will undergo sentinel lymph node biopsy as part of their treatment for recurrent breast cancer. They will also receive standard treatments, including surgery and adjuvant therapies as recommended by their healthcare team. conditions: Recurrent Breast Cancer studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 97 type: ESTIMATED name: Reoperative Sentinel Lymph Node Biopsy measure: Re-Sentinel Lymph node harvesting rate measure: Drainage pathways description measure: Complications rate measure: Axillary metastasis rate measure: Correlation Between Axillary and Internal Mammary Chain Infiltration measure: Quality of life in recurrent breast cancer sex: ALL minimumAge: 18 Years maximumAge: 100 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Hospital Clínic de Barcelona status: RECRUITING city: Barcelona zip: 08036 country: Spain name: Ines Torras Caral role: CONTACT phone: 93 227 54 00 phoneExt: 2499 email: itorras@clinic.cat lat: 41.38879 lon: 2.15899 hasResults: False
nctId: NCT06329076 id: BAM_lab_eyetracking_04 briefTitle: Losartan Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study overallStatus: RECRUITING date: 2024-03-05 date: 2025-06-01 date: 2025-07-30 date: 2024-03-25 date: 2024-04-11 name: University of Electronic Science and Technology of China class: OTHER briefSummary: The main aim of the present study is to investigate the effects of orally administered losartan on the perception of time-to-collision of threatening and non-threatening stimuli by combining a validated looming fear eye-tracking paradigm with a randomized between-subject placebo-controlled pharmacological trial design. conditions: Healthy studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: BASIC_SCIENCE masking: DOUBLE maskingDescription: Randomized placebo-controlled double-blind between-subject design whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 80 type: ESTIMATED name: Losartan name: Placebo measure: Ratio of judged-time-to-collision to actual-time-to-collision for threatening versus non-threatening stimuli after losartan administration measure: First saccade latency(ms) for threatening versus non-threatening stimuli after losartan administration measure: Fixation duration(ms) for threatening versus non-threatening stimuli after losartan administration sex: ALL minimumAge: 18 Years maximumAge: 40 Years stdAges: ADULT facility: University of Electronic Science and Technology of China status: RECRUITING city: Chengdu state: Sichuan country: China name: Weihua Zhao, Dr role: CONTACT phone: 86-28-61830811 email: zarazhao.uestc@outlook.com lat: 30.66667 lon: 104.06667 hasResults: False
nctId: NCT06329063 id: BAM_lab_eyetracking_03 briefTitle: Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study overallStatus: RECRUITING date: 2024-03-05 date: 2025-06-01 date: 2025-07-30 date: 2024-03-25 date: 2024-04-11 name: University of Electronic Science and Technology of China class: OTHER briefSummary: The main aim of the present study is to investigate the effects of orally administered vasopressin (AVP) on the perception of time-to-collision of threatening and non-threatening stimuli by combining a validated looming fear eye-tracking paradigm with a randomized between-subject placebo-controlled pharmacological trial design. conditions: Healthy studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: BASIC_SCIENCE masking: DOUBLE maskingDescription: Randomized placebo-controlled double-blind between-subject design whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 80 type: ESTIMATED name: Vasopressin name: Placebo measure: Ratio of judged-time-to-collision to actual-time-to-collision for threatening versus non-threatening stimuli after oral vasopressin administration measure: First saccade latency(ms) for threatening versus non-threatening stimuli after oral vasopressin administration measure: Fixation duration(ms) for threatening versus non-threatening stimuli after oral vasopressin administration sex: ALL minimumAge: 18 Years maximumAge: 40 Years stdAges: ADULT facility: University of Electronic Science and Technology of China status: RECRUITING city: Chendu state: Sichuan country: China name: Weihua Zhao, Dr role: CONTACT phone: 86-28-61830811 email: zarazhao.uestc@outlook.com hasResults: False
nctId: NCT06329050 id: BAM_lab_eyetracking_02 briefTitle: The Effects of Losartan on Attention Control: An Eye-tracking Study overallStatus: RECRUITING date: 2024-03-05 date: 2025-06-01 date: 2025-07-30 date: 2024-03-25 date: 2024-04-11 name: University of Electronic Science and Technology of China class: OTHER briefSummary: The main aim of the present study is to investigate the effects of orally administered Losartan on bottom-up and top-down attentional control to socio-emotional stimuli by combining a validated saccade/antisaccade eye-tracking paradigm with a randomized between-subject placebo-controlled pharmacological trial design. conditions: Healthy studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: BASIC_SCIENCE masking: DOUBLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 80 type: ESTIMATED name: Losartan name: Placebo measure: Saccade/antisaccade latency difference between social and non-social stimuli after losartan administration measure: Error rate of saccade/antisaccade for social versus non-social stimuli after losartan administration measure: Saccade/antisaccade latency for different facial emotions after losartan administration measure: Error rate of saccade/antisaccade for different facial emotions after losartan administration sex: ALL minimumAge: 18 Years maximumAge: 40 Years stdAges: ADULT facility: University of Electronic Science and Technology of China status: RECRUITING city: Chengdu state: Sichuan zip: 611731 country: China name: Weihua Zhao, Dr role: CONTACT phone: 86-28-61830811 email: zarazhao.uestc@outlook.com lat: 30.66667 lon: 104.06667 hasResults: False
nctId: NCT06329037 id: BAM_lab_eye-tracking_01 briefTitle: The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study overallStatus: RECRUITING date: 2024-03-05 date: 2025-06-01 date: 2025-07-30 date: 2024-03-25 date: 2024-04-11 name: University of Electronic Science and Technology of China class: OTHER briefSummary: The main aim of the present study is to investigate the effects of orally administered vasopressin (AVP) on bottom-up and top-down attentional control to socio-emotional stimuli by combining a validated saccade/antisaccade eye-tracking paradigm with a randomized between-subject placebo-controlled pharmacological trial design. conditions: Healthy studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Randomized placebo-controlled double-blind between-subject design primaryPurpose: BASIC_SCIENCE masking: DOUBLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 80 type: ESTIMATED name: Vasopressin name: Placebo measure: Saccade/antisaccade latency difference between social and non-social stimuli after oral vasopressin administration measure: Error rate of saccade/antisaccade for social versus non-social stimuli after oral vasopressin administration measure: Saccade/antisaccade latency for different facial emotions after oral vasopressin administration measure: Error rate of saccade/antisaccade for different facial emotions after oral vasopressin administration sex: ALL minimumAge: 18 Years maximumAge: 40 Years stdAges: ADULT facility: University of Electronic Science and Technology of China status: RECRUITING city: Chengdu state: Sichuan zip: 611731 country: China name: Weihua Zhao, Dr role: CONTACT phone: 86-28-61830811 email: zarazhao.uestc@outlook.com lat: 30.66667 lon: 104.06667 hasResults: False
nctId: NCT06329024 id: myofascial dysphagiapoststrok briefTitle: The Impact of Myofascial Release Therapy on Dysphagia in Post-stroke Patients overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary: The goal of this clinical trial is to explore Clinical Effect of Myofascial Release Therapy in Dysphagic Stroke Survivors. The main question it aims to answer is:
• Can Myofascial Release Therapy improve swallowing function in Stroke Survivors? Patients will be randomly allocated into the control group or the experimental group, all under rehabilitation treatment, the experimental group will be given Myofascial Release Therapy. The study lasts 21 days for each patient. Researchers will compare the Functional Oral Intake Scale, Penetration-Aspiration Scale, Swallowing Quality of Life to see if the Myofascial Release Therapy can help improve the situation. conditions: Dysphagia studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 80 type: ESTIMATED name: Rehabilitation treatment name: Myofascial Release Therapy measure: Penetration-Aspiration Scale measure: Swallowing Quality of Life questionnaire measure: Patient health questionnaire-9 measure: Functional Oral Intake Scale sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06329011 id: TDC+IOE briefTitle: Combining Transcranial Direct Current Stimulation With Intermittent Oral to Esophageal Tube for Stroke-related Dysphagia overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary: The study is a double-blind randomized controlled trial, lasting for 15 days for each participant. Patients with post-stroke dysphagia who receive treatment at the Rehabilitation Department are selected as the study subjects. The patients are randomly assigned to either the experimental group or the placebo group. All patients receive routine rehabilitation therapy and swallowing rehabilitation training, along with enteral nutrition support using Intermittent Oro-esophageal Tube. In addition to these interventions, patients in the experimental group receive transcranial direct current stimulation, while the instruments used for patients in the placebo group only illuminate an indicator light without any actual effect. conditions: Stroke studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 80 type: ESTIMATED name: Comprehensive rehabilitation therapy name: Intermittent Oro-esophageal Tube Feeding name: Transcranial direct current stimulation name: Placebo Transcranial direct current stimulation measure: Penetration Aspiration Scale measure: Functional Oral Intake Scale measure: Swallowing Quality of Life Questionnaire measure: Patient Health Questionnaire-9 measure: Body weight sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06328998 id: Intra-articular Injection briefTitle: Intra-articular Injection Versus Normal Rehabilitation Therapy on Temporomandibular Joint Dysfunction overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-12 date: 2024-12 date: 2024-03-25 date: 2024-03-25 name: Copka Sonpashan class: OTHER_GOV briefSummary: The goal of this clinical trial is to study about the clinical effect of Intra-articular Injection on Temporomandibular Joint Dysfunction